These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9774275)

  • 1. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.
    Wang R; Doolan DL; Le TP; Hedstrom RC; Coonan KM; Charoenvit Y; Jones TR; Hobart P; Margalith M; Ng J; Weiss WR; Sedegah M; de Taisne C; Norman JA; Hoffman SL
    Science; 1998 Oct; 282(5388):476-80. PubMed ID: 9774275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids.
    Wang R; Doolan DL; Charoenvit Y; Hedstrom RC; Gardner MJ; Hobart P; Tine J; Sedegah M; Fallarme V; Sacci JB; Kaur M; Klinman DM; Hoffman SL; Weiss WR
    Infect Immun; 1998 Sep; 66(9):4193-202. PubMed ID: 9712767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
    J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.
    Wang R; Epstein J; Charoenvit Y; Baraceros FM; Rahardjo N; Gay T; Banania JG; Chattopadhyay R; de la Vega P; Richie TL; Tornieporth N; Doolan DL; Kester KE; Heppner DG; Norman J; Carucci DJ; Cohen JD; Hoffman SL
    J Immunol; 2004 May; 172(9):5561-9. PubMed ID: 15100299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First DNA malaria vaccine on trial in Africa.
    Ferry G
    Curr Biol; 2000 Nov; 10(22):R810-1. PubMed ID: 11102816
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.
    Wang R; Epstein J; Baraceros FM; Gorak EJ; Charoenvit Y; Carucci DJ; Hedstrom RC; Rahardjo N; Gay T; Hobart P; Stout R; Jones TR; Richie TL; Parker SE; Doolan DL; Norman J; Hoffman SL
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10817-22. PubMed ID: 11526203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.
    Schneider J; Langermans JA; Gilbert SC; Blanchard TJ; Twigg S; Naitza S; Hannan CM; Aidoo M; Crisanti A; Robson KJ; Smith GL; Hill AV; Thomas AW
    Vaccine; 2001 Sep; 19(32):4595-602. PubMed ID: 11535306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3.
    Aidoo M; Lalvani A; Gilbert SC; Hu JT; Daubersies P; Hurt N; Whittle HC; Druihle P; Hill AV
    Infect Immun; 2000 Jan; 68(1):227-32. PubMed ID: 10603392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.
    Wizel B; Houghten R; Church P; Tine JA; Lanar DE; Gordon DM; Ballou WR; Sette A; Hoffman SL
    J Immunol; 1995 Jul; 155(2):766-75. PubMed ID: 7541824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of a multivalent DNA vaccine for malaria.
    Hedstrom RC; Doolan DL; Wang R; Gardner MJ; Kumar A; Sedegah M; Gramzinski RA; Sacci JB; Charoenvit Y; Weiss WR; Margalith M; Norman JA; Hobart P; Hoffman SL
    Springer Semin Immunopathol; 1997; 19(2):147-59. PubMed ID: 9406343
    [No Abstract]   [Full Text] [Related]  

  • 11. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
    Prieur E; Gilbert SC; Schneider J; Moore AC; Sheu EG; Goonetilleke N; Robson KJ; Hill AV
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):290-5. PubMed ID: 14694197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria DNA vaccines in Aotus monkeys.
    Gramzinski RA; Maris DC; Doolan D; Charoenvit Y; Obaldia N; Rossan R; Sedegah M; Wang R; Hobart P; Margalith M; Hoffman S
    Vaccine; 1997 Jun; 15(8):913-5. PubMed ID: 9234546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.
    Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.
    Richie TL; Charoenvit Y; Wang R; Epstein JE; Hedstrom RC; Kumar S; Luke TC; Freilich DA; Aguiar JC; Sacci JB; Sedegah M; Nosek RA; De La Vega P; Berzins MP; Majam VF; Abot EN; Ganeshan H; Richie NO; Banania JG; Baraceros MF; Geter TG; Mere R; Bebris L; Limbach K; Hickey BW; Lanar DE; Ng J; Shi M; Hobart PM; Norman JA; Soisson LA; Hollingdale MR; Rogers WO; Doolan DL; Hoffman SL
    Hum Vaccin Immunother; 2012 Nov; 8(11):1564-84. PubMed ID: 23151451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP).
    Sedegah M; Kim Y; Ganeshan H; Huang J; Belmonte M; Abot E; Banania JG; Farooq F; McGrath S; Peters B; Sette A; Soisson L; Diggs C; Doolan DL; Tamminga C; Villasante E; Hollingdale MR; Richie TL
    Malar J; 2013 Jun; 12():185. PubMed ID: 23738590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in epitope recognition, isotype and titer of antisera to Plasmodium falciparum merozoite surface protein 4 raised by different modes of DNA or protein immunization.
    Wang L; Menting JG; Black CG; Stowers A; Kaslow DC; Hoffman SL; Coppel RL
    Vaccine; 2000 Nov; 19(7-8):816-24. PubMed ID: 11115704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.
    Gómez-Duarte OG; Pasetti MF; Santiago A; Sztein MB; Hoffman SL; Levine MM
    Infect Immun; 2001 Feb; 69(2):1192-8. PubMed ID: 11160021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
    Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
    Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.
    Epstein JE; Charoenvit Y; Kester KE; Wang R; Newcomer R; Fitzpatrick S; Richie TL; Tornieporth N; Heppner DG; Ockenhouse C; Majam V; Holland C; Abot E; Ganeshan H; Berzins M; Jones T; Freydberg CN; Ng J; Norman J; Carucci DJ; Cohen J; Hoffman SL
    Vaccine; 2004 Apr; 22(13-14):1592-603. PubMed ID: 15068840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.